Articles and Editorials|

Article on Rotaject® Technology featured in World Pharmaceutical Frontiers

B News Page 740x540

The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver next-generation, high viscosity formulations all the while putting patient comfort and usability first. Building upon more than 10 years of experience with autoinjectors for highly viscous drugs, SHL’s Rotaject® technology is the ultimate solution for this challenge.

This groundbreaking technology has been featured in the 2017 spring edition of World Pharmaceutical Frontiers magazine. To learn more about the Rotaject® technology, read the full article HERE.

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery systems such as autoinjectors, pen injectors and advanced inhaler systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.

With locations in Switzerland, Taiwan, Sweden, and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com   
Share:

Related News